The advent of immune checkpoint inhibitors heralded a new dawn in cancer treatment, yet their promise remains unfulfilled for the vast majority of patients who show little to no response to these potentially life-saving drugs. This central paradox has left clinicians and researchers searching for a
As millions of people around the globe clock in for shifts that extend into the late hours and overnight, a large-scale study has revealed a concerning and previously underappreciated occupational hazard connected to their work schedules. This comprehensive investigation provides significant new
For millions grappling with the profound and persistent darkness of major depression, the journey to find an effective treatment can be a long and disheartening road, but a landmark clinical trial has now provided powerful evidence that an implanted medical device offers substantial and lasting
With over two decades of research in biopharma, Ivan Kairatov has witnessed the evolution of microbiome science from a niche interest into a central player in our understanding of health. As an expert in R&D and technological innovation, he has a unique perspective on the translational gap—the
A conservative West Virginia lawmaker and a progressive California governor rarely find common ground, yet they have become improbable allies in a sweeping national movement to fundamentally reshape what Americans eat and how public health is managed. This decentralized but powerful crusade,
With deep expertise in biopharmaceutical research and development, Ivan Kairatov has a front-row seat to the breakthroughs and setbacks that define modern medicine. He joins us to dissect the recent turbulence in the multiple sclerosis (MS) treatment landscape, where a promising new class of drugs
